Thyroid cancer prognostic biomarker ARL4A and its relationship with immune infiltration.

Xiaoyong HanJianping LiaoYaoping ZhouXiaohua HuHaishan Wu

Published in: International journal of clinical and experimental pathology (2024)

ARL4A may serve as a potential biomarker for the diagnosis and treatment of THCA, impacting the prognosis of patients through the modulation of the immune microenvironment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
stem cells
prognostic factors
peritoneal dialysis
patient reported outcomes